Abstract:Anthocyanins, found in various pigmented plants as secondary metabolites, represent a class of dietary polyphenols known for their bioactive properties, demonstrating health-promoting effects against several chronic diseases. Among these, cyanidin-3-O-glucoside (C3G) is one of the most prevalent types of anthocyanins. Upon consumption, C3G undergoes phases I and II metabolism by oral epithelial cells, absorption in the gastric epithelium, and gut transformation (phase II & microbial metabolism), with limited amounts reaching the bloodstream. Obesity, characterized by excessive body fat accumulation, is a global health concern associated with heightened risks of disability, illness, and mortality. This comprehensive review delves into the biodegradation and absorption dynamics of C3G within the gastrointestinal tract. It meticulously examines the latest research findings, drawn from in vitro and in vivo models, presenting evidence underlining C3G's bioactivity. Notably, C3G has demonstrated significant efficacy in combating obesity, by regulating lipid metabolism, specifically decreasing lipid synthesis, increasing fatty acid oxidation, and reducing lipid accumulation. Additionally, C3G enhances energy homeostasis by boosting energy expenditure, promoting the activity of brown adipose tissue, and stimulating mitochondrial biogenesis. Furthermore, C3G shows potential in managing various prevalent obesity-related conditions. These include cardiovascular diseases (CVD) and hypertension through the suppression of reactive oxygen species (ROS) production, enhancement of endogenous antioxidant enzyme levels, and inhibition of the nuclear factor-kappa B (NF-κB) signaling pathway and by exercising its cardioprotective and vascular effects by decreasing pulmonary artery thickness and systolic pressure which enhances vascular relaxation and angiogenesis. Type 2 diabetes mellitus (T2DM) and insulin resistance (IR) are also managed by reducing gluconeogenesis via AMPK pathway activation, promoting autophagy, protecting pancreatic β-cells from oxidative stress and enhancing glucose-stimulated insulin secretion. Additionally, C3G improves insulin sensitivity by upregulating GLUT-1 and GLUT-4 expression and regulating the PI3K/Akt pathway. C3G exhibits anti-inflammatory properties by inhibiting the NF-κB pathway, reducing pro-inflammatory cytokines, and shifting macrophage polarization from the pro-inflammatory M1 phenotype to the anti-inflammatory M2 phenotype. C3G demonstrates antioxidative effects by enhancing the expression of antioxidant enzymes, reducing ROS production, and activating the Nrf2/AMPK signaling pathway. Moreover, these mechanisms also contribute to attenuating inflammatory bowel disease and regulating gut microbiota by decreasing Firmicutes and increasing Bacteroidetes abundance, restoring colon length, and reducing levels of inflammatory cytokines. The therapeutic potential of C3G extends beyond metabolic disorders; it has also been found effective in managing specific cancer types and neurodegenerative disorders. The findings of this research can provide an important reference for future investigations that seek to improve human health through the use of naturally occurring bioactive compounds.

Cyanidin 3-Glucoside Attenuates Obesity-Associated Insulin Resistance and Hepatic Steatosis in High-Fat Diet-Fed and Db/db Mice Via the Transcription Factor FoxO1.

Dietary Cyanidin-3-Glucoside Attenuates High-Fat-Diet-Induced Body-Weight Gain And Impairment Of Glucose Tolerance In Mice Via Effects On The Hepatic Hormone Fgf21

Cyanidin-3-O-β-glucoside, a Typical Anthocyanin, Exhibits Antilipolytic Effects in 3T3-L1 Adipocytes During Hyperglycemia: Involvement of FoxO1-mediated Transcription of Adipose Triglyceride Lipase.

Cyanidin-3-glucoside Attenuates High-Fat and High-Fructose Diet-Induced Obesity by Promoting the Thermogenic Capacity of Brown Adipose Tissue

Inhibitory Effects of Sweet Cherry Anthocyanins on the Obesity Development in C57bl/6 Mice

A dietary anthocyanin cyanidin-3-O-glucoside binds to PPARs to regulate glucose metabolism and insulin sensitivity in mice

Cyanidin-3-glucoside increases whole body energy metabolism by upregulating brown adipose tissue mitochondrial function.

Front Cover: Cyanidin‐3‐glucoside Increases Whole Body Energy Metabolism by Upregulating Brown Adipose Tissue Mitochondrial Function

Impact of Cyanidin-3-Glucoside on Gut Microbiota and Relationship with Metabolism and Inflammation in High Fat-High Sucrose Diet-Induced Insulin Resistant Mice

Cyanidin-3-O-β-glucoside improves obesity and triglyceride metabolism in KK-Ay mice by regulating lipoprotein lipase activity.

Cyanidin-3-O-Glucoside Supplementation Ameliorates Metabolic Insulin Resistance via Restoration of Nitric Oxide-Mediated Endothelial Insulin Transport

Recent advances on cyanidin-3-O-glucoside in preventing obesity-related metabolic disorders: A comprehensive review

Cyanidin 3-Glucoside Protects 3T3-L1 Adipocytes Against H2O2- or TNF-alpha-induced Insulin Resistance by Inhibiting C-Jun NH2-terminal Kinase Activation.

Cyanidin and delphinidin modulate inflammation and altered redox signaling improving insulin resistance in high fat-fed mice

Green Tea Catechin Epigallocatechin Gallate Alleviates High‐fat Diet‐induced Obesity in Mice by Regulating the Gut–brain Axis

Cyanidin-3-O-β-glucoside Protects Primary Mouse Hepatocytes Against High Glucose-Induced Apoptosis by Modulating Mitochondrial Dysfunction and the PI3K/Akt Pathway.

A Review of the Role of an Anthocyanin, Cyanidin-3- O- β-glucoside in Obesity-Related Complications

The Anthocyanin Cyanidin-3-o-β-glucoside, a Flavonoid, Increases Hepatic Glutathione Synthesis and Protects Hepatocytes Against Reactive Oxygen Species During Hyperglycemia: Involvement of a Camp–pka-Dependent Signaling Pathway

GC-(4→8)-GCG, A Proanthocyanidin Dimer from Camellia ptilophylla, Modulates Obesity and Adipose Tissue Inflammation in High-Fat Diet Induced Obese Mice

Procyanidin Attenuates Weight Gain and Modifies the Gut Microbiota in High Fat Diet Induced Obese Mice

Anthocyanin Improves Glucose Homeostasis in Obese Mice Via Beneficial Regulation of Intestinal Microbiota and Barrier Function (OR34-08-19).